These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 26159926)
1. Novel insights into the apoptosis mechanism of DNA topoisomerase I inhibitor isoliquiritigenin on HCC tumor cell. Li ZX; Li J; Li Y; You K; Xu H; Wang J Biochem Biophys Res Commun; 2015 Aug; 464(2):548-53. PubMed ID: 26159926 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of DNA topoisomerase inhibitor isoliquiritigenin on the growth of glioma cells. Zhao S; Chang H; Ma P; Gao G; Jin C; Zhao X; Zhou W; Jin B Int J Clin Exp Pathol; 2015; 8(10):12577-82. PubMed ID: 26722447 [TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of C3-pyrazole/chalcone-linked beta-carboline hybrids: antitopoisomerase I, DNA-interactive, and apoptosis-inducing anticancer agents. Kamal A; Srinivasulu V; Nayak VL; Sathish M; Shankaraiah N; Bagul C; Reddy NV; Rangaraj N; Nagesh N ChemMedChem; 2014 Sep; 9(9):2084-98. PubMed ID: 24470122 [TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of topoisomerase I by pinostrobin: Molecular docking, spectroscopic and topoisomerase I activity studies. Jadaun A; Subbarao N; Dixit A J Photochem Photobiol B; 2017 Feb; 167():299-308. PubMed ID: 28122297 [TBL] [Abstract][Full Text] [Related]
6. α-Glucosidase inhibition by luteolin: kinetics, interaction and molecular docking. Yan J; Zhang G; Pan J; Wang Y Int J Biol Macromol; 2014 Mar; 64():213-23. PubMed ID: 24333230 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase. Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711 [TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733 [TBL] [Abstract][Full Text] [Related]
9. Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives. Wang YC; Qian C; Peng ZL; Hou XJ; Wang LL; Chao H; Ji LN J Inorg Biochem; 2014 Jan; 130():15-27. PubMed ID: 24145066 [TBL] [Abstract][Full Text] [Related]
10. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity. Tabassum S; Zaki M; Afzal M; Arjmand F Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526 [TBL] [Abstract][Full Text] [Related]
11. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines. Tabassum S; Afzal M; Arjmand F J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481 [TBL] [Abstract][Full Text] [Related]
12. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents. Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)} L-phenylalanine-DACH conjugate complexes: in vitro DNA binding, cleavage and molecular docking studies. Shamsi M; Yadav S; Arjmand F J Photochem Photobiol B; 2014 Jul; 136():1-11. PubMed ID: 24815057 [TBL] [Abstract][Full Text] [Related]
14. Topoisomerases inhibitory activities and DNA binding properties of 9-methoxycamptothecin from Nothapodytes nimmoniana (J. Graham) Mabberly. Wang H; Ao M; Liu W; Bai Y; Zhu Y; Yu L Nat Prod Res; 2019 Mar; 33(5):727-731. PubMed ID: 29130341 [TBL] [Abstract][Full Text] [Related]
15. 4β-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and IIα inhibitors and apoptosis inducing agents. Kamal A; Suresh P; Ramaiah MJ; Srinivasa Reddy T; Kapavarapu RK; Rao BN; Imthiajali S; Lakshminarayan Reddy T; Pushpavalli SN; Shankaraiah N; Pal-Bhadra M Bioorg Med Chem; 2013 Sep; 21(17):5198-208. PubMed ID: 23849207 [TBL] [Abstract][Full Text] [Related]
16. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells. Sudan S; Rupasinghe HP Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698 [TBL] [Abstract][Full Text] [Related]
17. Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis. Yuan X; Yu B; Wang Y; Jiang J; Liu L; Zhao H; Qi W; Zheng Q Recent Pat Anticancer Drug Discov; 2013 May; 8(2):191-9. PubMed ID: 22963151 [TBL] [Abstract][Full Text] [Related]
18. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Kim DC; Ramachandran S; Baek SH; Kwon SH; Kwon KY; Cha SD; Bae I; Cho CH Reprod Sci; 2008 Jul; 15(6):552-8. PubMed ID: 18487228 [TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro. Zhou GS; Song LJ; Yang B Mol Med Rep; 2013 Feb; 7(2):531-6. PubMed ID: 23229626 [TBL] [Abstract][Full Text] [Related]
20. Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation. Yan J; Zhang G; Hu Y; Ma Y Food Chem; 2013 Dec; 141(4):3766-73. PubMed ID: 23993547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]